<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652647/" ref="ordinalpos=2182&amp;ncbi_uid=4924986&amp;link_uid=PMC3652647" image-link="/pmc/articles/PMC3652647/figure/F7/" class="imagepopup">Figure 7.  From: Refractoriness of interferon-beta <span class="highlight" style="background-color:">signaling</span> through NOD1 <span class="highlight" style="background-color:">pathway</span> in mouse respiratory epithelial cells using the anticancer xanthone compound. </a></div><br /><div class="p4l_captionBody">Schematic model of probable pathway of refractoriness of interferon-β signal. Previous works have shown that 5,6-dimethylxanthenone-4-acetic acid (DMXAA) can activate TANK-binding kinase1 (TBK1) to initiate interferon (IFN) regulatory factor 3 (IRF3) signaling and nucleotide oligomerization domain 1 (NOD1) that interacts with rip-like interacting caspase-like apoptosis-regulatory protein kinase to activate nuclear factor-κB (NF-κB) signal pathway that regulates production of inflammatory cytokines/chemokines[11-13]. Our results indicate that DMXAA can induce refractoriness of interferon-β signal through NOD1 tolerance in mouse respiratory epithelial cells.</div></div>